Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 20, 204-211, February 1, 1960]
© 1960 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malmgren, H.
Right arrow Articles by Sylvén, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malmgren, H.
Right arrow Articles by Sylvén, B.

The Histological Distribution of Glutathione Reductase Activity in Solid Mouse Tumor Transplants and a Comparison with Ascites Tumors and Normal Tissues*

Harry Malmgren{dagger} and Bengt Sylvén

( The Cancer Research Division of Radiumhemmet, Karolinska Institutet, Radiumhemmet, Stockholm 60, Sweden)

The topographical distribution of GSSG reductase activity has been investigated at the histological level in solid unicentric transplants of three different types of autonomous mouse tumors. Assays have been performed on fresh frozen serial microtome sections, with an average protein content of about 20 µg. This technic permits sufficient separation in space for sampling of the peripheral tumor regions containing the young growing cells and the more central regions carrying older cell generations.

In continuous series of tumor sections there has been no proportionality between the observed activity and the pertinent tumor cell numbers per sample. The young and rapidly growing tumor cells have at least 4–6 times as much GSSG reductase activity per cell than the still vital nongrowing central tumor cell types.

The distribution of GSSG reductase runs closely parallel to the catheptic activity of the same tumors.

The GSSG reductase activity of solid tumors has been compared with that of ascites tumor cells and some normal mouse tissue. The calculated activity of the investigated growing tumor cell is about twice that of normal mouse liver cells. The average activity of two ascites tumor cell populations was found to be low, and that of cultured strain L cells was comparable with the activity of normal mouse fibroblasts.

The marked biochemical differences between the two main classes of cells in solid tumor transplants have been emphasized.

* This investigation was supported by institutional grants from the King Gustaf V's Jubilee Fund, the Swedish Cancer Society, and the Jane Coffin Childs Memorial Fund, all of which are gratefully acknowledged.

{dagger} Present address: Leo Pharmaceutical Co., Inc., Hälsingborg, Sweden.

Received 7/20/59.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1960 by the American Association for Cancer Research.